How much funding has Synchron raised?

Synchron has raised $325.0M in total funding, most recently a Series D round.

Who are Synchron's investors?

Synchron's investors include Khosla Ventures, Double Point Ventures, ARCH Venture Partners, Arch Capital Group, Bezos Expeditions.

Where is Synchron headquartered?

Synchron is headquartered in New York, New York, United States.

What industry is Synchron in?

Synchron operates in Biotech, Hardware, Healthcare.

Synchron

The brain-computer interface device powering autonomy

New York, United States · Founded 2016 · $325.0M raised

Biotech

Hardware

Healthcare

Headquarters: New York, New York
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: synchron.com
Total Funding: $325.0M
Last Round: $200.0M Series DNov 2025
Rounds: 4

About

Synchron is developing a minimally invasive brain-computer interface (BCI) called Stentrode, implanted via endovascular procedure without open brain surgery. It enables people with paralysis to control digital devices using thoughts, restoring autonomy and addressing unmet medical needs in neurology.

Summary

Synchron is a Biotech company based in New York, United States, founded in 2016. It has raised $325.0M in total across 4 rounds, most recently a $200.0M Series D round in Nov 2025. Investors include Khosla Ventures, Double Point Ventures and ARCH Venture Partners.

LinkedIn X (Twitter)